Respiratory syncytial virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms.

Jessica Rose, PHD., reads from the RSV Arexvy vaccine insert, pointing out that, “Evidence from an animal model strongly suggests that AREXVY would be unsafe in individuals younger than 2 years of age because of an increased risk of enhanced respiratory disease.”

Jessica goes on to point out that the language in the insert is careful stated so that the vaccine could be added to the childhood schedule, despite the clear risk to young people.

To learn more, watch the full episode on CHD.TV!